Barclays analyst Matt Miksic raised the firm’s price target on Alphatec (ATEC) to $20 from $19 and keeps an Overweight rating on the shares. After exceeding Street expectations for sales growth, EBITDA, and easing working capital and capex, Alphatec looks on track to be cash flow positive in Q4 and free cash flow breakeven with double-digit EBITDA margins in 2025, the analyst tells investors in a research note.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATEC:
- Alphatec files to sell 1.13M shares of common stock for holders
- Microsoft reports Q1 beat, Comcast weighs cable networks spinoff: Morning Buzz
- Alphatec’s Strong Q3 Boosts Revenue Forecasts
- Closing Bell Movers: Microsoft, Meta both down about 3% despite earnings beats
- Alphatec raises FY24 revenue view to $605M from $602M, consensus $602.1M